IGC Pharma (IGC) Debt Ratio (2011 - 2026)

IGC Pharma (IGC) has reported Debt Ratio for 16 consecutive years, with 0.18 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Debt Ratio rose 1086.84% year-over-year to 0.18 in Q1 2026; TTM through Mar 2026 was 0.18, a 1086.84% increase from a year earlier, with the FY2026 full-year figure at 0.18, up 1086.84% from the prior year.
• Debt Ratio was 0.18 for Q1 2026 at IGC Pharma, up from 0.05 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.18 in Q1 2026 and troughed at 0.01 in Q1 2022.
• A 5-year average of 0.02 and a median of 0.01 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio tumbled 77.32% in 2022 and soared 1086.84% in 2026, its largest moves.
• Over 5 years, Debt Ratio stood at 0.01 in 2022, then soared by 74.46% to 0.01 in 2023, then rose by 20.43% to 0.01 in 2024, then jumped by 242.5% to 0.05 in 2025, then jumped by 259.64% to 0.18 in 2026.
• The last three Debt Ratio figures came in at 0.18 (Q1 2026), 0.05 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.